Obesity Exacerbates Rat Cerebral Ischemic Injury through Enhancing Ischemic Adiponectin-Containing Neuronal Apoptosis

Molecular Neurobiology

Volumn 53, Issue 6, 2016, Pages 3702-3713

  Wu, Ming Hsiu ^a,b   Chio, Chung Ching ^b   Tsai, Kuen Jer ^a   Chang, Ching Ping ^c   Lin, Nan Kai ^d   Huang, Chao Ching ^a,e   Lin, Mao Tsun ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d Li Sheng Biotechnology Co   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Cerebral ischemia; Obesity; P38 mitogen activated protein kinase; Stroke

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38; 4',6 DIAMIDINO 2 PHENYLINDOLE; ADIPONECTIN RECEPTOR; CELL NUCLEUS ANTIGEN; INDOLE DERIVATIVE; NERVE PROTEIN; NEUN PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE EXACERBATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; UPREGULATION; WESTERN DIET; ANIMAL; BACULOVIRIDAE; BRAIN; CELL COUNT; CEREBRAL ARTERY DISEASE; COMPLICATION; DOWN REGULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADIPONECTIN; ANIMALS; ANTIGENS, NUCLEAR; APOPTOSIS; BACULOVIRIDAE; BRAIN; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL COUNT; DISEASE PROGRESSION; DOWN-REGULATION; INDOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; NEURONS; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADIPONECTIN; UP-REGULATION;

EID: 84934777242     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9305-0     Document Type: Article

References (36)

1. Chen MP, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, Lee YJ (2005) Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25(4):821–826
2. Stott DJ, Welsh P, Rumley A, Robertson M, Ford I, Sattar N, Westendorp RG, Jukema JW et al (2009) Adipocytokines and risk of stroke in older people: a nested case–control study. Int J Epidemiol 38(1):253–261
3. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD (2005) Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36(9):1915–1919
4. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, Lee KH (2007) Adiponectin levels in patients with intracranial atherosclerosis. Neurology 68(22):1931–1937
5. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, Shin HK, Moskowitz MA et al (2008) Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117(2):216–223
6. Greenwood CE, Winocur G (1990) Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 53(1):74–87
7. Johnson PM, Kenny PJ (2010) Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 13(5):635–641
8. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB (2010) Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303(15):1490–1497
9. Dubinion JH, da Silva AA, Hall JE (2010) Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. J Hypertens 28(7):1466–1470
10. Hendrickx H, McEwen BS, Ouderaa F (2005) Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention. Neurobiol Aging 26(Suppl 1):1–5
11. McNeilly AD, Williamson R, Sutherland C, Balfour DJ, Stewart CA (2011) High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav Brain Res 217(1):134–141
12. Langdon KD, Clarke J, Corbett D (2011) Long-term exposure to high fat diet is bad for your brain: Exacerbation of focal ischemic brain injury. Neuroscience 182:82–87. doi:10.1016/j.neuroscience.2011.03.028
13. Gartshore G, Patterson J, Macrae IM (1997) Influence of ischemia and reperfusion on the course of brain tissue swelling and blood–brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 147(2):353–360
14. Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24(1):117–121
15. van Oers MM (2011) Opportunities and challenges for the baculovirus expression system. J Invertebr Pathol 107(Suppl):S3–S15. doi:10.1016/j.jip.2011.05.001, Review
16. Hu YC (2005) Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26(4):405–416, Review
17. Andersen MN, Mouritzen CV, Gabrieli E (1966) Mechanisms of plasma hemoglobin clearance after acute hemolysis: Studies in open-heart surgical patients. Ann Surg 163(4):529–536
18. Hu JS, Gelman DB, Blackburn MB (2003) Age-specific interaction between the parasitoid, Encarsia formosa and its host, the silverleaf whitefly, Bemisia tabaci (Strain B). J Insect Sci 3:28
19. Jones RN, Barry AL (1988) In-vitro activity of ampicillin/sulbactam against cefoxitin-resistant anaerobic bacteria. J Antimicrob Chemother 21(1):135–138
20. O’Reilly DR, Miller LK, Luckow VA (1994) Baculovirus expression vectors: a laboratory manual. Oxford University Press, New York
21. Lo HR, Chao YC (2004) Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnol Prog 20(1):354–360
22. Chen SF, Hsu CW, Huang WH, Wang JY (2008) Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br J Pharmacol 155(8):1279–1296. doi:10.1038/bjp.2008.345
23. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17(6):1304–1308
24. Wang CC, Chio CC, Chang CH, Kuo JR, Chang CP (2010) Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. BMC Pharmacol 10:11. doi:10.1186/1471-2210-10-11
25. Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JE (2004) Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol 189(1):122–130
26. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ et al (2006) American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37(6):1583–1633
27. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116(7):1784–1792, Review
28. Shetty S, Kusminski CM, Scherer PE (2009) Adiponectin in health and disease: Evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 30(5):234–239
29. Matsuzawa Y (2010) Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci 86(2):131–141, Review
30. Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, Li YI, Woodruff TM, Taylor SM et al (2010) Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med 2(1):15. doi:10.1186/2040-7378-2-15
31. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S et al (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464(7293):1313–1319. doi:10.1038/nature08991
32. Wanninger J, Neumeier M, Weigert J, Bauer S, Weiss TS, Schäffler A, Krempl C, Bleyl C et al (2009) Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways. Am J Physiol Gastrointest Liver Physiol 297(3):G611–G618. doi:10.1152/ajpgi.90644.2008
33. Tang CH, Lu ME (2009) Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 69(16):1781–1789. doi:10.1002/pros.21029
34. Chen B, Liao WQ, Xu N, Xu H, Wen JY, Yu CA, Liu XY, Li CL et al (2009) Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 1273:129–137. doi:10.1016/j.brainres.2009.04.002
35. Shen L, Miao J, Yuan F, Zhao Y, Tang Y, Wang Y, Zhao Y, Yang GY (2013) Overexpression of adiponectin promotes focal angiogenesis in the mouse brain following middle cerebral artery occlusion. Gene Ther 20(1):93–101. doi:10.1038/gt.2012.7
36. Shimano M, Ouchi N, Shibata R, Ohashi K, Pimentel DR, Murohara T, Walsh K (2010) Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. J Mol Cell Cardiol 49(2):210–220. doi:10.1016/j.yjmcc.2010.02.021